Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: RMD

ResMed Inc.

Healthcare | Medical - Devices

Market prices for RMD are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (FY2026)$10.43

ResMed Inc. (NYSE: RMD) is a medical device company. Figures from SEC EDGAR; updated 2026-10-22 01:30 UTC.

What ResMed Inc. does

ResMed is a global digital health company that designs cloud-connected medical devices and software to treat chronic respiratory conditions and support residential care. The company pioneered CPAP treatment for obstructive sleep apnea and has since expanded into a range of respiratory devices, diagnostic products, masks, accessories, and cloud-based health applications that help clinicians manage patients and encourage treatment adherence.

Summarized from ResMed Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (FY2026)$10.43
Return on equity23.13%
Debt/equity0.10

Revenue, margins & earnings

FY2022 Net income: $779MFY2022 Taxes & interest: $221MFY2022 Operating expenses: $1.02BFY2022 Cost of revenue: $1.55B$3.58BFY2022FY2023 Net income: $898MFY2023 Taxes & interest: $234MFY2023 Operating expenses: $1.22BFY2023 Cost of revenue: $1.87B$4.22BFY2023FY2024 Net income: $1.02BFY2024 Taxes & interest: $299MFY2024 Operating expenses: $1.34BFY2024 Cost of revenue: $2.03B$4.69BFY2024FY2025 Net income: $1.40BFY2025 Taxes & interest: $285MFY2025 Operating expenses: $1.37BFY2025 Cost of revenue: $2.09B$5.15BFY2025FY2026 Net income: $1.52BFY2026 Taxes & interest: $363MFY2026 Operating expenses: $1.57BFY2026 Cost of revenue: $2.20B$5.65BFY2026
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-08
  • 2026-10-08Chairman and CEOSale-4,991$1.13M
  • 2026-10-08Chairman and CEOOption exercise4,991$730.4K
  • 2026-10-08Chairman and CEOResMed Common Stock OptionsOption exercise-4,991—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does ResMed Inc. do?

ResMed is a global digital health company that designs cloud-connected medical devices and software to treat chronic respiratory conditions and support residential care.

When did RMD last file with the SEC?

ResMed Inc.'s most recent SEC filing on record is a 8-K filed 2026-07-07. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-22 01:30 UTC. This page is also available as JSON at /api/data?ticker=RMD and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for RMD and 5,000+ tickers.

Create a free account — keep RMD
For your agent
GET /api/data?ticker=RMD

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt